Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy

Status unconfirmed · Phase 1 · Has a placebo group

Conditions studied: Cerebral Palsy

In brief

Assessing the effects of noninvasive spinal cord neuromodulation on improving function in individuals with cerebral palsy

Key facts

Study ID

NCT04882592

Run by

SpineX Inc.

People needed

50

Starts

2021-05-15

Expected to finish

2024-12-01

Last updated by the study team

2023-04-04

Who can join

Age: 2 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 1) individuals above the age of 2 years of age and 2) diagnosed with cerebral palsy (CP). The exclusion criteria included 1) children with selective dorsal root rhizotomy, 2) intramuscular Botox injection in the preceding 12 months, 3) current antispastic medications 4) unhealed fractures or contractures that would prevent them from performing functional tasks and 5) tendon lengthening surgeries.

You may not qualify if…

• Intramuscular Botox injection in the past 12 months

Where it is running

• SpineX — Los Angeles, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.